{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:49:33Z","timestamp":1772012973241,"version":"3.50.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijdp.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.drugpo.2014.01.009","type":"journal-article","created":{"date-parts":[[2014,1,26]],"date-time":"2014-01-26T09:50:53Z","timestamp":1390729853000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs"],"prefix":"10.1016","volume":"25","author":[{"given":"Nick","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Verster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Rodolph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00042560-199901010-00011","article-title":"Survival of HIV-1 in syringes","volume":"20","author":"Abdala","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7517-5-25","article-title":"The effectiveness of behavioural interventions in the primary prevention of hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned","volume":"5","author":"Abou-Saleh","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jurban\/jti016","article-title":"Adherence to hepatitis B virus vaccination at syringe exchange sites","volume":"82","author":"Altice","year":"2005","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0020","first-page":"CD004147","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","volume":"10","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0025","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"Amin","year":"2004","journal-title":"HIV Medicine"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.drugpo.2009.07.001","article-title":"The reach of a free hepatitis B vaccination programme: Results of a Dutch study among drug users","volume":"21","author":"Baars","year":"2010","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2014.01.009_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1016\/j.drugpo.2014.01.009_bib0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: A systematic review","volume":"7","author":"Baral","year":"2007","journal-title":"Lancet Infectious Diseases"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2014.01.009_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0168-8278(02)80354-3","article-title":"Efficacy of a short-schedule\/high dose hepatitis B vaccination in drug users","volume":"36","author":"Brissette","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2014.01.009_bib0050","first-page":"42","article-title":"Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention","volume":"113","author":"Broadhead","year":"1998","journal-title":"Public Health Reports"},{"issue":"10","key":"10.1016\/j.drugpo.2014.01.009_bib0055","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1086\/644771","article-title":"Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression","volume":"49","author":"Chen","year":"2009","journal-title":"Clinical Infectious Diseases"},{"issue":"29\u201330","key":"10.1016\/j.drugpo.2014.01.009_bib0060","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1016\/j.vaccine.2004.04.011","article-title":"Hepatitis B, vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. [Clinical Trial Randomized Controlled Trial Research Support, Non-U. S. Gov\u2019t]","volume":"22","author":"Christensen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0065","series-title":"Global state of harm reduction 2008: Mapping the response to drug-related HIV and hepatitis C epidemics","author":"Cook","year":"2008"},{"issue":"8","key":"10.1016\/j.drugpo.2014.01.009_bib0070","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. [Multicenter StudyResearch Support, Non-U. S. Gov\u2019t]","volume":"21","author":"Danta","year":"2007","journal-title":"AIDS"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2014.01.009_bib0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.drugalcdep.2009.11.013","article-title":"Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. [Research Support, Non-U. S. Gov\u2019t]","volume":"108","author":"Day","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.drugpo.2014.01.009_bib0080","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2105\/AJPH.91.11.1791","article-title":"Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs. on-site vaccination at a syringe exchange program. [Comparative Study]","volume":"91","author":"Des Jarlais","year":"2001","journal-title":"American Journal of Public Health"},{"issue":"14","key":"10.1016\/j.drugpo.2014.01.009_bib0085","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2014.01.009_bib0090","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dieterich","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-4505-4-17","article-title":"Improving the use of research evidence in guideline development: 5. Group processes","volume":"4","author":"Fretheim","year":"2006","journal-title":"Health Research Policy and Systems\/BioMed Central"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1478-4505-4-27","article-title":"Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines","volume":"4","author":"Fretheim","year":"2006","journal-title":"Health Research Policy and Systems\/BioMed Central"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0105","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s10461-009-9651-x","article-title":"A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users. [Randomized Controlled TrialResearch Support, Non-U. S. Gov\u2019t]","volume":"14","author":"Gagnon","year":"2010","journal-title":"AIDS and Behavior"},{"issue":"14","key":"10.1016\/j.drugpo.2014.01.009_bib0110","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/QAD.0b013e32823f9066","article-title":"A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users. [Randomized Controlled TrialResearch Support, U.S. Gov\u2019t, P. H. S.]","volume":"21","author":"Garfein","year":"2007","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.drugpo.2014.01.009_bib0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10654-006-9023-z","article-title":"Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002. [Research Support, Non-U. S. Gov\u2019t]","volume":"21","author":"Gerlich","year":"2006","journal-title":"European Journal of Epidemiology"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0120","doi-asserted-by":"crossref","DOI":"10.1097\/COH.0b013e328354bd44","article-title":"Tuberculosis and HIV in people who inject drugs: evidence for action for TB, HIV, prison and harm reduction services","author":"Getahun","year":"2012","journal-title":"Current Opinion in HIV AIDS"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.009_bib0125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/10852351003640914","article-title":"Couple-based HIV, prevention for injecting drug users in Kazakhstan: a pilot intervention study. [Randomized Controlled Trial]","volume":"38","author":"Gilbert","year":"2010","journal-title":"Journal of Prevention & Intervention in the Community"},{"issue":"9244","key":"10.1016\/j.drugpo.2014.01.009_bib0130","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0140-6736(00)03232-3","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study","volume":"356","author":"Greub","year":"2000","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.drugpo.2014.01.009_bib0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1016\/j.drugpo.2014.01.009_bib0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000320287","article-title":"Liquid drugs and high dead space syringes may keep HIV and HCV prevalence high\u2014A comparison of Hungary and Lithuania. [Comparative Study Research Support, N.I.H., Extramural]","volume":"16","author":"Gyarmathy","year":"2010","journal-title":"European Addiction Research"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2008.10.014","article-title":"The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary. [Comparative Study]","volume":"100","author":"Gyarmathy","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a009792","article-title":"Syringe exchange and risk of infection with hepatitis B and C viruses. [Comparative StudyResearch Support, U.S. Gov\u2019t, P. H. S.]","volume":"149","author":"Hagan","year":"1999","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs","volume":"204","author":"Hagan","year":"2011","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2105\/AJPH.91.1.42","article-title":"Sharing of drug preparation equipment as a risk factor for hepatitis C","volume":"91","author":"Hagan","year":"2001","journal-title":"American Journal of Public Health"},{"issue":"6899","key":"10.1016\/j.drugpo.2014.01.009_bib0165","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/bmj.307.6899.276","article-title":"Hepatitis B vaccination: Protection for how long and against what?","volume":"307","author":"Hall","year":"1993","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0170","article-title":"Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to hepatitis C virus seroprevalence","author":"Hanafiah","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0175","unstructured":"Kirby Institute. (2011). Australian NSP Survey. In J. Iversen, L. Topp & L. Maher (Eds.), Prevalence of HIV, HCV and injecting and sexual behaviour among Needle and Syringe Program attendees. National Data Report 1995\u20132010. Sydney."},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2003.10.007","article-title":"Hepatitis B virus infection and vaccination among young injection and non-injection drug users: Missed opportunities to prevent infection. [Research Support, U.S. Gov\u2019t, P. H. S.]","volume":"73","author":"Kuo","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2014.01.009_bib0185","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2105\/AJPH.2007.113415","article-title":"A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C. [Multicenter StudyRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov\u2019t]","volume":"98","author":"Latka","year":"2008","journal-title":"American Journal of Public Health"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2014.01.009_bib0190","first-page":"151","article-title":"Outreach in natural settings: The use of peer leaders for HIV prevention among injecting drug users\u2019 networks","volume":"113","author":"Latkin","year":"1998","journal-title":"Public Health Reports"},{"issue":"6","key":"10.1016\/j.drugpo.2014.01.009_bib0195","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2105\/AJPH.93.6.919","article-title":"Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study. [Research Support, Non-U.S. Gov\u2019t Research Support, U.S. Gov\u2019t, P. H. S.]","volume":"93","author":"Lum","year":"2003","journal-title":"American Journal of Public Health"},{"issue":"7","key":"10.1016\/j.drugpo.2014.01.009_bib0200","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2105\/AJPH.94.7.1218","article-title":"Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons","volume":"94","author":"Macalino","year":"2004","journal-title":"American Journal of Public Health"},{"issue":"5","key":"10.1016\/j.drugpo.2014.01.009_bib0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00002030-200403260-00007","article-title":"Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: Harmful impact of nevirapine","volume":"18","author":"Macias","year":"2004","journal-title":"AIDS"},{"issue":"9719","key":"10.1016\/j.drugpo.2014.01.009_bib0210","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"issue":"9651","key":"10.1016\/j.drugpo.2014.01.009_bib0215","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0220","first-page":"CD007192","article-title":"Psychosocial interventions for reducing injection and sexual risk behaviour for preventing HIV in drug users","author":"Meader","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"28","key":"10.1016\/j.drugpo.2014.01.009_bib0225","first-page":"945","article-title":"Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men\u2014New York City, 2005\u20132010","volume":"60","author":"MMWR","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"7","key":"10.1016\/j.drugpo.2014.01.009_bib0230","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.52.7.1035","article-title":"Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients","volume":"52","author":"Mohsen","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.009_bib0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2003-39947","article-title":"Hepatotoxicity of nucleoside reverse transcriptase inhibitors","volume":"23","author":"Montessori","year":"2003","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0240","unstructured":"National Institute for Health and Clinical Excellence (NICE). (2008). Drug misuse: Psychosocial interventions (2011\/08\/12 ed.). Leicester, UK: British Psychological Society."},{"key":"10.1016\/j.drugpo.2014.01.009_bib0245","series-title":"Evidence for action: Effectiveness of community-based outreach in preventing HIV\/AIDS among injecting drug use","author":"Needle","year":"2004"},{"issue":"9791","key":"10.1016\/j.drugpo.2014.01.009_bib0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t Review]","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.009_bib0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/nur.20371","article-title":"Predictors of HAV\/HBV vaccination completion among methadone maintenance clients","volume":"33","author":"Nyamathi","year":"2009","journal-title":"Research in Nursing & Health"},{"issue":"12","key":"10.1016\/j.drugpo.2014.01.009_bib0260","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"issue":"9576","key":"10.1016\/j.drugpo.2014.01.009_bib0265","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(07)60675-8","article-title":"Use of evidence in WHO recommendations. [Research Support, Non-U. S. Gov\u2019t]","volume":"369","author":"Oxman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1478-4505-4-14","article-title":"Improving the use of research evidence in guideline development: 2, Priority setting","volume":"4","author":"Oxman","year":"2006","journal-title":"Health research policy and systems\/BioMed Central"},{"issue":"7","key":"10.1016\/j.drugpo.2014.01.009_bib0275","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/656212","article-title":"Survival of hepatitis C virus in syringes: Implication for transmission among injection drug users","volume":"202","author":"Paintsil","year":"2010","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2014.01.009_bib0280","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1360-0443.2011.03765.x","article-title":"Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment","volume":"107","author":"Pouget","year":"2012","journal-title":"Addiction"},{"issue":"9401","key":"10.1016\/j.drugpo.2014.01.009_bib0285","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.drugpo.2014.01.009_bib0290","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.vaccine.2005.12.045","article-title":"Hepatitis vaccination among drug users. [Review]","volume":"24","author":"Quaglio","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.009_bib0295","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1360-0443.2009.02765.x","article-title":"The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic","volume":"105","author":"Ramasamy","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2014.01.009_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2014.01.009_bib0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/10550880903183034","article-title":"A trial to reduce hepatitis C seroincidence in drug users. [Randomized Controlled Trial Research Support, N.I.H., Extramural]","volume":"28","author":"Stein","year":"2009","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0310","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2009.09.006","article-title":"Drug users\u2019 adherence to a 6-month vaccination protocol: effects of motivational incentives. [Comparative Study Research Support, N.I.H., Extramural]","volume":"107","author":"Stitzer","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl. 2","key":"10.1016\/j.drugpo.2014.01.009_bib0315","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2013.04.013","article-title":"A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia","author":"Topp","year":"2013","journal-title":"Preventive Medicine"},{"issue":"9","key":"10.1016\/j.drugpo.2014.01.009_bib0330","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1360-0443.2004.00809.x","article-title":"Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users. [Clinical Trial Randomized Controlled Trial Research Support, Non-U. S. Gov\u2019t]","volume":"99","author":"Tucker","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0335","unstructured":"UNESC. (2009). Economic and Social Council resolution E\/2009\/L.23, 24 July."},{"key":"10.1016\/j.drugpo.2014.01.009_bib0340","unstructured":"United Nations General Assembly. International covenant on civil and political rights Res 2200A (XXI). (1966)."},{"key":"10.1016\/j.drugpo.2014.01.009_bib0345","series-title":"International guidelines on HIV\/AIDS and human rights","author":"UNHCR","year":"2006"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0510","unstructured":"United Nations (UN). Universal Declaration of Human Rights, Geneva, UN, 1948 http:\/\/www.un.org\/en\/documents\/udhr\/index.shtml."},{"issue":"4","key":"10.1016\/j.drugpo.2014.01.009_bib0350","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0168-8278(02)00213-1","article-title":"Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998\u20132000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners","volume":"37","author":"van Steenbergen","year":"2002","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2014.01.009_bib0355","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1572-0241.2004.04150.x","article-title":"Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study","volume":"99","author":"Vandelli","year":"2004","journal-title":"American Journal of Gastroenterology"},{"issue":"11","key":"10.1016\/j.drugpo.2014.01.009_bib0360","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence?. Model projections for different epidemic settings. [Research Support, Non-U. S. Gov\u2019t]","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0365","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugpo.2012.10.006","article-title":"Could low dead-space syringes really reduce HIV transmission to low levels?. [Comment Research Support, Non-U. S. Gov\u2019t Review]","volume":"24","author":"Vickerman","year":"2013","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0515","unstructured":"Viral hepatitis. EB126.R16. World Health Assembly. 126th Session. 23 January 2010 (2007)."},{"issue":"3","key":"10.1016\/j.drugpo.2014.01.009_bib0370","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/QAI.0b013e318050d8d8","article-title":"Recognition of hepatitis C virus coinfection in HIV-positive injecting drug users in Asia","volume":"45","author":"Walsh","year":"2007","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0375","series-title":"Global State of Harm Reduction 2010: Key issues for broadening the response.","article-title":"The silent epidemic: Responding to viral hepatitis among people who inject drugs","author":"Walsh","year":"2010"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0385","series-title":"Effectiveness of community-based outreach in preventing HIV\/AIDS among injecting drug users","author":"WHO","year":"2004"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0390","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","author":"WHO","year":"2008"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0395","first-page":"405","article-title":"HBV vaccines: WHO position paper","volume":"84","author":"WHO","year":"2009","journal-title":"Weekly Epidemiological Record"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0400","article-title":"Hepatitis B vaccines: WHO position paper-recommendations","author":"WHO","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0405","series-title":"Mental Health Gap Action Programme (mhGAP) intervention guide for mental, neurological and substance abuse disorders in non-specialised health settings","author":"WHO","year":"2010"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0410","series-title":"World Health Assembly Resolution: WHO's role and responsibilities in health research","author":"WHO","year":"2010"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0415","series-title":"Adapting WHO normative HIV guidelines for national programmes: essential principles and processes","author":"WHO","year":"2011"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0420","series-title":"Hepatitis C. (Fact sheet Number 164)","author":"WHO","year":"2011"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0425","series-title":"Guidance on prevention of viral hepatitis B and C among people who inject drugs","author":"WHO","year":"2012"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0430","series-title":"WHO Handbook for guideline development","author":"WHO","year":"2012"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0435","series-title":"Global HIV\/AIDS response: Epidemic update and health sector progress towards universal access","author":"WHO","year":"2011"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0440","series-title":"Evidence for action series","author":"WHO","year":"2007"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0445","series-title":"Policy guidelines for collaborative TB and HIV services for injecting and other drug users: An integrated approach","author":"WHO","year":"2008"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0450","series-title":"Interventions to address HIV in prisons. Evidence for action technical papers","author":"WHO","year":"2007"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0455","series-title":"Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users","author":"WHO","year":"2009"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0460","series-title":"Technical guidance for countries to set targets for universal access to HIV prevention, Treatment and acre for injecting drug users. 2012 revision","author":"WHO","year":"2012"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0465","series-title":"Needle sharing among intravenous drug abusers: National and international perspectives","first-page":"137","article-title":"Combining ethnographic and epidemiological methods in targeted AIDS interventions: The Chicago model","author":"Wiebel","year":"1988"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0470","series-title":"The indigenous leader outreach model: Intervention manual","author":"Wiebel","year":"1993"},{"issue":"Suppl. 8","key":"10.1016\/j.drugpo.2014.01.009_bib0475","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/01.aids.0000304706.79541.ef","article-title":"Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov\u2019t]","volume":"21","author":"Wu","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0480","series-title":"Cross sectional survey to evaluate the association between using and sharing high dead space syringes (HDSSs) or low dead space syringes (LDSSs) and prevalent HIV and hepatitis C virus (HCV) among IDUs","author":"Zule","year":"2009"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0485","unstructured":"Zule, W. (2012). RTI International."},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2014.01.009_bib0490","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.2105\/AJPH.2007.126854","volume":"99","author":"Zule","year":"2009","journal-title":"American Journal of Public Health"},{"issue":"1","key":"10.1016\/j.drugpo.2014.01.009_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2012.07.002","article-title":"Are major reductions in new HIV infections possible with people who inject drugs?.The case for low dead-space syringes in highly affected countries. [Research Support, N. I. H., Extramural Research Support, Non-U. S. Gov\u2019t Review]","volume":"24","author":"Zule","year":"2013","journal-title":"The International Journal on Drug Policy"},{"issue":"7","key":"10.1016\/j.drugpo.2014.01.009_bib0500","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0277-9536(01)00256-8","article-title":"Syringe type and drug injector risk for HIV infection: A case study in Texas. [Evaluation Studies Research Support, U.S. Gov\u2019t, P. H. S.]","volume":"55","author":"Zule","year":"2002","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.drugpo.2014.01.009_bib0505","series-title":"Poster presented at NIDA International Forum","article-title":"Variations in needles and syringes used by injecting drug users","author":"Zule","year":"2010"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T17:43:34Z","timestamp":1597427014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395914000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0955395914000127"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.01.009","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}